Clinical trials are research studies that help doctors learn whether new treatments, medications, or medical approaches are safe and effective. However, not everyone interested in joining a study will be eligible to participate. In fact, it’s common for people to be screened out during the process, and there are several reasons why you can’t join a clinical trial.
While that may be disappointing, it is in no way a reflection on your health or value. But you might still be wondering, “What can disqualify you from a clinical trial?”
Each study has specific eligibility criteria that determine who can safely take part. These requirements are designed to protect participants and ensure the study produces accurate results, which is why eligibility can vary between trials.
Keep reading to learn why you may be disqualified from a clinical trial.
Every clinical trial has inclusion and exclusion criteria that determine who is a good fit for a particular study and who may be better suited for a different study.
The inclusion criteria outline the requirements for a qualified potential participant.
Exclusion criteria determine which participants are ineligible to enroll in the trial. Clinical trial eligibility hinges on these rules to ensure participant safety, maintain study consistency, and produce reliable data and results.
The process for determining who qualifies for a clinical trial involves multiple layers of oversight and regulatory review. According to Terence R. Flotte, MD, Dean of the School of Medicine at UMass Medical, where his focus as principal investigator is on Pediatric and Gene Therapy, “the inclusion and exclusion criteria are contributed to both by the investigator at the site and the sponsor of the trial, and those inputs are all subject to approval at the institution by the IRB, the Institutional Review Board, which oversees the ethics of human research, and by the FDA, that regulates the use of investigational therapies.”
There are several reasons why you might not qualify for a clinical trial, and it’s important to remember that being excluded from a clinical trial does not mean you’ll be prohibited from participating in one in the future.
Some trials depend on your prior medical history. Because safety is the primary goal of any clinical trial, if you’re taking medications to treat other conditions or diseases, those medications could cause drug interactions, leading to unwanted or dangerous side effects.
The opposite is also true: there are times when, to qualify for a trial, you have to meet an additional condition to be included as a participant. This is often true for trials of medical treatments and drugs that researchers want to ensure are safe for people with a variety of conditions. This Real World Data Collection enables trial results that more accurately reflect the community.
It’s no surprise that our bodies change with age, so there may be age requirements or considerations that could affect a potential participant’s clinical trial eligibility. Often, clinical trials set an upper age limit because new drugs typically lack a safety profile. That being said, it is ethically important to consider the safety of exposing vulnerable populations to early-phase treatments.
“Inclusion criteria are the way we determine who should be in the trial, and exclusion is more based on who shouldn’t be in the trial, and that’s based generally both on what might be effective and on what might be safe,” Dr. Flotte explained. “An example would be sometimes the inclusion criteria might be only be for one particular type of mutation in a gene because perhaps that is the way the drug is designed to work; it works only on one mutation and so while you may hear, ‘oh there’s a trial for muscular dystrophy,’ when you go and look at it it’s only for a certain subtype that has a particular gene mutation.”
By weighing clinical trial exclusion criteria against a potential enrollee’s medical records, pre-trial labs, and physical exam findings, researchers can rule out participants who don’t qualify. These pre-trial screenings preserve resources, mitigate risks, and, to the patient’s benefit, avoid unnecessary in-person visits.
This process works to improve trial efficacy, yielding the best, most accurate, and safest results. For example, an important neurological trial, the Cleveland Brain Study, begins with an initial phone screening after participants express interest. The phone screening saves time, money, and resources for both the trial facilitator and the prospective enrollee.
In the case of the Cleveland Brain Study, which is currently seeking adults over 50, all visits must be held at the center located in Cleveland, so the phone screening helps site coordinators ensure that those who enroll have reliable transportation and reside in the local area.
It’s easy to overthink and get in your head about being disqualified from a clinical trial, but exclusion criteria are strict, and disqualification is not a judgment on your health, nor is it an indicator of future eligibility. Yes, you can be turned away from a clinical trial, but the good news is that countless trials are going on at any given time; it’s just a matter of finding the right one for you.
Medical research is constant, and safety is a primary concern. If you were excluded from a trial, know that it is in your best interest, and there’s likely another option out there for you. If you’re looking for something specific to treat your particular diagnosis, visit BlackDoctor’s Clinical Trials Resource Center or contact your physician to discuss your options or help you find the right trial.
If you’re looking for additional information or want to know about other trials you may qualify for, use the ClinicalTrials.gov registry in conjunction with the advice of your healthcare provider to determine your clinical trial eligibility.
One of the key facets of a clinical trial is the informed consent doctrine. Informed consent ensures patient-centered care, allowing patients to make voluntary, informed decisions about their treatment. It involves clear, concise communication between the patient and the healthcare provider. It ensures the patient is fully informed about the medication, process, or treatment, as well as its potential benefits and risks. Informed consent also allows the patient to withdraw it at any time.
Clinical trials are entirely voluntary. Participants have the right to withdraw from a study at any time and for any reason without penalty. If you decide to discontinue your participation, it is important to inform the study coordinator or principal investigator as soon as possible. They can help ensure that any necessary medical steps — such as safely tapering off study medications, transitioning treatments, or completing follow-up evaluations — are handled appropriately. Communicating with the research team before leaving the study helps protect your health and ensures that the discontinuation process is managed as safely and smoothly as possible.
Clinical trials play an essential role in advancing medicine, but they also rely on carefully regulated eligibility criteria to keep participants safe and produce meaningful results. Because every study has different goals, it’s common for people to qualify for some trials and not others. Being ineligible for a particular study doesn’t mean you’ve done anything wrong or that research opportunities are unavailable to you. In many cases, it simply means that another study may be a better fit.
By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.
